ON MAY 7, THE REMNANTS OF GENETIC TESTING GIANT INVITAE (NYSE: NVTA) were scooped up by Labcorp when the United States Bankruptcy Court approved Labcorp’s bid to acquire Invitae’s assets. Labcorp will receive “select assets of Invitae on a going concern basis for $239 million in cash consideration, plus other non-cash consideration,” PR Newswire noted. […]
Invitae’s Troubled Journey: Rise, Fall, and Bankruptcy
Investors poured billions into the genetic testing firm, but the outcome was billions in losses and liquidation
- By Robert Michel
- > From the Volume XXXI, No. 10 - July 22, 2024 Issue
